A new obesity framework reveals hidden health risks in people with normal BMI and urges a shift in diagnosis from ...

BMI, or body mass index, is an outdated measurement that fails to properly identify health risks, according to a new study.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

After menopause, individuals with cardiovascular disease and weight gain may face a higher risk of breast cancer, recent ...

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research materials to sidestep regulatory scrutiny.

Obesity rates for Black children and adolescents are 22.4% in the decade before the pandemic and 35% in the 2 years after the height of the COVID pandemic.

A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI. Here's what they recommend using instead.

Trend alert! Split dosing, stretch dosing, skip dosing, microdosing Ozempic… People are finding creative ways to use ...

Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts is sharing new recommendations for how to use it.

A new report concludes only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and over-diagnosing people who don't currently deal with the negative ...

Still, it is premature to declare that GLP-1s have caused overall declining obesity rates in the US. There are a number of ways to interpret the CDC data, and not all of them suggest that obesity ...